[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"relapsed-hepatoblastoma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:relapsed-hepatoblastoma":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100482024","relapsed-and-refractory-hepatoblastoma-a-prospective-registry-and-liver-tumor-research-consortium-initiative-100482024",false,"NCT05556642","Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative","Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Hepatic Tumors Research Consortium Initiative","Inclusion Criteria:\n\n* All patients of any age with a suspected diagnosis (per treating oncologist\u002Fsurgeon) or confirmed diagnosis of a rrHBL and all patients with Hepatocellular Malignant Neoplasm- Not Otherwise Specified (HCN-NOS) who are \\\u003C6 years of age at the time of initial diagnosis\n* To allow for tumor modelling to be performed with fresh tissue from these cases, patients with suspected rrHBL are eligible to enroll on study\n* Unless the patient is deceased, all patients and\u002For one parent or legal guardian must provide written informed consent as well as HIPAA\u002Frelease of information consent\n\nExclusion Criteria:\n\n* None","ALL",{"count":18,"type":19},500,"ESTIMATED","20 Years","OBSERVATIONAL","There are limited data regarding the biology and treatment of relapsed\u002Frefractory hepatoblastoma (rrHBL). This project provides the infrastructure for acquisition of biological specimens, imaging, and correlative clinical data to facilitate biology studies and characterization of rrHBL. This registry will collect clinical, demographic, and pathological data, specimens (as available) and imaging from patients with rrHBL, prospectively. Cases are identified through:\n\n1. Existing clinical and\u002For cancer registry databases\n2. Referrals from clinicians, surgeons, or pathologists\n3. Families initiating contact with Registry staff directly",[24,25],"Relapsed Hepatoblastoma","Refractory Hepatoblastoma","RECRUITING","2026-03-16",{"date":29,"type":30},"2026-03-18","ACTUAL",{"date":32,"type":30},"2022-09-07",{"date":34,"type":19},"2040-09-01",{"name":36,"class":37},"Children's Hospital Medical Center, Cincinnati","OTHER"]